Equities

electroCore, Inc.

electroCore, Inc.

Actions
Health CareMedical Equipment and Services
  • Price (USD)7.24
  • Today's Change0.218 / 3.11%
  • Shares traded33.35k
  • 1 Year change+19.64%
  • Beta0.6108
Data delayed at least 15 minutes, as of May 08 2024 20:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

  • Revenue in USD (TTM)16.03m
  • Net income in USD-18.83m
  • Incorporated2005
  • Employees68.00
  • Location
    electroCore, Inc.200 FORGE WAY, SUITE 205ROCKAWAY 07866United StatesUSA
  • Phone+1 (973) 290-0097
  • Fax+1 (973) 290-9171
  • Websitehttps://www.electrocore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Precision Optics Corporation Inc19.22m-1.72m34.23m84.00--3.02--1.78-0.289-0.2893.271.871.094.315.09228,782.90-9.77-6.71-13.54-10.5533.3533.65-8.94-5.021.10-10.390.1823--34.2339.1284.42--19.39--
SeaStar Medical Holding Corp0.00-26.23m35.22m12.00---------1.28-1.280.00-0.29130.00----0.00-800.85-----------------26.51---------115.19------
Nutriband Inc2.09m-5.49m36.75m13.00--4.61--17.62-0.6863-0.68630.26220.72670.24576.1515.94---64.63-55.21-72.05-66.7441.3433.32-263.05-315.870.854-82.630.0312--0.274153.43-22.35--65.57--
LENSAR Inc42.16m-14.38m37.15m130.00--1.10--0.881-1.34-1.343.774.160.67231.547.65324,338.50-22.93-30.97-28.10-36.9450.0651.04-34.11-52.302.64--0.00--19.2511.5727.77---42.91--
iCAD Inc17.32m-7.01m37.18m67.00--1.11--2.15-0.2742-0.19250.67471.270.37190.80342.16258,477.60-15.06-23.94-19.23-34.1485.3776.96-40.48-45.024.26--0.00---12.54-7.5329.32--23.88--
Inspira Technologies Oxy BHN Ltd0.00-11.29m38.22m37.00--6.03-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Co-Diagnostics Inc6.81m-35.33m39.39m155.00--0.4579--5.78-1.20-1.200.23212.750.06241.203.6343,948.71-32.365.77-33.856.1538.5782.24-518.6810.9410.52--0.000.00-80.09179.54-148.15--101.27--
United Health Products Inc0.00-2.62m41.47m6.00---------0.011-0.0110.00-0.0070.000.00--0.00-826.01-6,446.86------53.19---132,561.200.0606-20.88-----100.00---55.45------
electroCore, Inc.16.03m-18.83m42.14m68.00--5.66--2.63-3.56-3.562.911.240.78471.3528.68235,735.30-92.19-70.73-146.63-88.9682.5175.81-117.49-352.821.49--0.00--86.5774.4215.02---5.88--
IRIDEX Corp51.87m-9.57m45.51m111.00--4.78--0.8774-0.5934-0.59343.220.58591.352.938.01467,288.30-24.95-19.54-37.31-27.4642.0442.67-18.45-15.451.35--0.00---8.964.02-26.81---24.35--
Vaso Corp81.02m4.81m45.58m300.008.661.707.850.56260.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
DarioHealth Corp20.35m-63.51m47.99m276.00--0.7623--2.36-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
Apyx Medical Corp52.35m-18.71m48.85m252.00--1.83--0.9331-0.5403-0.54031.510.77070.79911.714.25207,734.10-28.78-25.24-35.57-29.9764.4966.11-36.01-46.004.74-12.810.5526--17.6125.8219.28--7.99--
InspireMD Inc6.21m-19.92m49.61m65.00--1.17--8.00-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Milestone Scientific Inc9.83m-6.93m50.37m17.00--6.22--5.13-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
Data as of May 08 2024. Currency figures normalised to electroCore, Inc.'s reporting currency: US Dollar USD

Institutional shareholders

15.98%Per cent of shares held by top holders
HolderShares% Held
AWM Investment Co., Inc.as of 31 Dec 2023550.36k9.17%
The Vanguard Group, Inc.as of 31 Dec 2023152.56k2.54%
Geode Capital Management LLCas of 31 Dec 202351.85k0.86%
Renaissance Technologies LLCas of 31 Dec 202348.42k0.81%
Wealthspire Advisors LLCas of 31 Dec 202347.50k0.79%
International Assets Investment Management LLCas of 31 Dec 202335.40k0.59%
Jaffe Tilchin Investment Partners LLCas of 31 Dec 202326.90k0.45%
PFG Investments LLCas of 31 Mar 202418.00k0.30%
G1 Execution Services LLCas of 31 Dec 202314.93k0.25%
SSgA Funds Management, Inc.as of 31 Dec 202313.07k0.22%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.